Announcements Trials

Browse Landscape

Phase

Status

Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 107 Precursor Cell Lymphoblastic Leukemia-Lymphoma 38 Leukemia 23 Lymphoma 20 Recurrence 16 Burkitt Lymphoma 16 Lymphoma, Mantle-Cell 13 Neoplasms, Plasma Cell 11 Lymphoma, Non-Hodgkin 11 Waldenstrom Macroglobulinemia 9 Lymphoma, Follicular 9 Immunoglobulin Light-chain Amyloidosis 9 Hodgkin Disease 9 Breast Neoplasms 9 Vomiting 8 Neoplasms 8 Nausea 8 Lymphoma, B-Cell, Marginal Zone 8 Lymphoma, Large B-Cell, Diffuse 7 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 6 Lymphoma, T-Cell, Cutaneous 6 Leukemia, Lymphocytic, Chronic, B-Cell 6 Amyloidosis 6 Leukemia, Myeloid, Acute 5 Smoldering Multiple Myeloma 4 Sezary Syndrome 4 Mycosis Fungoides 4 Lymphoma, Large-Cell, Immunoblastic 4 Lung Neoplasms 4 Blast Crisis 4

Interventions

Surveys and Questionnaires 4 Acupuncture Therapy 2 Sugars 1 Rehabilitation 1 Oxygen 1 Lisinopril 1 Fentanyl 1 Exercise 1 Dexamethasone 1 Calcium Dobesilate 1 Buspirone 1 Behavior Therapy 1 Aromatherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Dyspnea × Calcium Dobesilate × Clear all

NCT01670097 2021-02-17

Dexamethasone Dyspnea Study

M.D. Anderson Cancer Center

Phase 2 Completed

52 enrolled 13 charts

Dyspnea, Hematologic Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡